⚡️💥🇺🇸#SRNE
Sorrento Mexico, Mexico Government Execute Memorandum of Understanding for Rapid Clinical Development of COVID-19 Vaccines
Sorrento Mexico, Mexico Government Execute Memorandum of Understanding for Rapid Clinical Development of COVID-19 Vaccines
⚡️💥🇺🇸#SRNE
Sorrento to Obtain Exclusive Rights in N and S Amer, Europe, Major Asian Countries, Certain Other Countries to Utilize Dyadic's C1 Technology
#DYAI Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic's Lead Cvid-19 Vaccine Candidate and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Sorrento to Obtain Exclusive Rights in N and S Amer, Europe, Major Asian Countries, Certain Other Countries to Utilize Dyadic's C1 Technology
#DYAI Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic's Lead Cvid-19 Vaccine Candidate and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
⚡️💥🇺🇸#SRNE
Sorrento Therapeutics объявляет о вступлении в опционное соглашение c Texas A&M University System по эксклюзивной лицензии на ингибиторы MPRO против SARS-CoV-2
Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
Sorrento Therapeutics объявляет о вступлении в опционное соглашение c Texas A&M University System по эксклюзивной лицензии на ингибиторы MPRO против SARS-CoV-2
Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
🇺🇸#SRNE #препараты
Sorrento представила серию ингибиторов, которые могут потенциально использоваться при лечении от ковида
Sorrento представила серию ингибиторов, которые могут потенциально использоваться при лечении от ковида